Uncategorised - European Medical Journal

Immunological Profile of HTLV-1 in Pediatric Patients

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus associated with significant immunological dysregulation and oncogenesis…

Clinico-Epidemiological Characteristics and Diagnostics With Autopsy Findings of Rabies Encephalitis

Rabies is the deadliest infectious disease, with a nearly 100% fatality. Due to this fear, it is often an overlooked disease, resulting…

Genomic Test Guides Breast Cancer Therapy Duration

A recent analysis of the IDEAL clinical trial highlights a breakthrough for early-stage breast cancer.

Cancer Risk Elevated in Multiple Sclerosis: New Findings

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.

OSA Severity Linked to Postoperative Complications

Obstructive sleep apnea (OSA) severity may hold the key to predicting postoperative cardiorespiratory complications, according to a new study involving over 6,700 patients.

Donald Trump picks last role in health leadership team

President-elect Donald Trump has picked the final post in his health team, selecting Dr Jay Bhattacharya to be Director of the US National Institutes of Health.

Systemic Inflammation Links Psoriasis Severity to Cardiovascular Disease

Systemic inflammation mediates psoriasis severity’s link to cardiovascular disease, highlighting its importance in clinical care.

Combining Therapies Boosts Survival in Bladder Cancer

Predictive biomarkers are expected to play a pivotal role in further enhancing treatment outcomes as they can identify patients at higher risk of recurrence.

Hema Now: Episode 5: The Hidden Impact of Blood Disorders on Brain Health

In this episode of Hema Now, Jonathan Sackier welcomes Christopher Patriquin, a leading expert in the field of hematology and rare diseases…

Nicotinamide Riboside Reduces Airway Inflammation in Patients With COPD

Nicotinamide riboside reduces airway inflammation and boosts NAD+ levels in COPD patients, study shows.